Postsurgical Keytruda Plus Chemo May Benefit Patients With dMMR Endometrial Cancer
For patients with newly diagnosed high-risk endometrial cancer, postsurgical Keytruda (pembrolizumab) and chemotherapy with or without radiation did not result in an improvement to disease-free survival (DFS; the time after diagnosis a patient shows no …